Jupiter Asset Management Ltd. Raises Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Jupiter Asset Management Ltd. grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 4,494.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 548,237 shares of the company's stock after buying an additional 536,305 shares during the period. Jupiter Asset Management Ltd. owned approximately 0.25% of Bath & Body Works worth $21,255,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC purchased a new position in shares of Bath & Body Works in the 4th quarter worth $26,000. SRS Capital Advisors Inc. lifted its stake in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares during the last quarter. True Wealth Design LLC boosted its position in shares of Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after buying an additional 1,054 shares during the period. UMB Bank n.a. boosted its position in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after buying an additional 335 shares during the period. Finally, Lindbrook Capital LLC grew its stake in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after buying an additional 431 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Down 1.7 %

Shares of NYSE:BBWI opened at $29.29 on Thursday. The company has a market capitalization of $6.34 billion, a price-to-earnings ratio of 7.14, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The firm has a 50 day moving average of $36.72 and a 200 day moving average of $34.07.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.73%. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Bath & Body Works announced that its Board of Directors has approved a stock repurchase plan on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to buy up to 6.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Morgan Stanley decreased their price target on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a research note on Thursday, November 21st. Robert W. Baird lifted their target price on Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research report on Friday, February 28th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. JPMorgan Chase & Co. set a $47.00 price objective on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Telsey Advisory Group reissued an "outperform" rating and issued a $43.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.